Orthofix International | OFIX - Equity Capital And Reserves


Orthofix International reported $429.57M in Equity Capital and Reserves for its fiscal quarter ending in September of 2026.





Equity Capital And Reserves Change Date
Accuray USD 53.42M 8.45M Dec/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 446.4M 815K Sep/2026
AtriCure USD 533.22M 16.79M Sep/2026
Dexcom USD 2.54B 86M Sep/2026
EDAP TMS EUR 10.1M 13.22M Mar/2026
Globus Medical USD 4.8B 27.65M Sep/2026
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.58B 156.9M Sep/2026
Integra LifeSciences USD 1.07B 23.24M Sep/2026
J&J USD 81.53B 3.44B Sep/2026
Medtronic USD 50.23B 160M Jun/2026
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Orthofix International USD 429.57M 387K Sep/2026
Plus Therapeutics USD 5.46M 6.5M Jun/2026
Smith & Nephew USD 5.18B 356M Jun/2026
STAAR Surgical USD 376.13M 10.73M Sep/2026
Stryker USD 23.99B 1.01B Jun/2026
Tandem Diabetes Care USD 135.09M 4.7M Sep/2026
Teleflex USD 3.49B 589.18M Sep/2026
Veracyte USD 1.43B 44.86M Sep/2026
Zimmer Biomet Holdings USD 12.72B 83.1M Sep/2026